Shire Share Discussion Threads

[philo124] 12/2/2010 17:11

Holding up well.

[philo124] 20/1/2010 11:47

Spot on; earnings forecasts stop me taking my near 50% profit; could go over £14 in due course.

[the_doctor] 20/1/2010 11:10

It is due to hopes of healthcare reform in the US being hindered after a republican win.

[togo2] 20/1/2010 10:56

Somethings happening.Any news?

[the_doctor] 20/1/2010 10:21

There are now very few companies that could acquire Shire.
However, I do think there's a chance that Teva or A.N.Other might and perhaps at something like a price of 1400p.
For those reasons, I'm not willing to short this one.

[philo124] 11/1/2010 11:22

Some mkt sector takeover activity with Sanofi in US

[investinggarden] 11/1/2010 11:14

What Investment Stock Picks: Drugs tipped to take Shire to new high

[philo124] 05/1/2010 17:09

Nice Graph

[flyingswan] 14/12/2009 13:41

This article mentions a connection to Shire SHP and RNVO.

I would be please if you could take a look at Renovo Group RNVO their was a brokers upgrade to 80p in the Ft see article below:
I would be pleased to kow if you think the 80p is realistic on the chart?


Scar treatment prospects lift Renovo

By Neil Hume



Published: December 12 2009 02:00 | Last updated: December 12 2009 02:00

Renovo Group , the scar reduction technology group, moved higher yesterday after KBC Peel Hunt upgraded it to "buy" and set an 80p target price.

Analyst Paul Cuddon said Renovo should complete recruitment for the key clinical trial of Juvista, a treatment injected into skin at the edge of wounds to reduce scarring, in the next couple of months.

"We model peak sales of more than £300m ($500m) in this indication across the US [rights owned by Shire] and Europe [wholly owned by Renovo]," he said, adding that a stock overhang had also been cleared. Shares in Renovo rose 2.9 per cent to 27p.

[philo124] 16/11/2009 08:46

Ver Good rise!

[hamnavoe] 15/11/2009 11:37

have you got to pay stamp duty
when buying these shares ? tia.

[philo124] 06/11/2009 17:15

Throug £11

[philo124] 26/10/2009 17:58

Very Good update today, anyone notice?

[2ngh] 28/8/2009 10:17

Time for a breather maybe?

Could be a good short in this area (1038)

[philo124] 20/8/2009 08:34

Very useful site.Thanks

[foreignbuffett] 19/8/2009 18:43

found a downgrade on this site www.intermarketstocks.com

[philo124] 18/8/2009 09:07

iS THIS THE TOP?

[flyingswan] 25/6/2009 13:18

ABH could make a good defensive play if we see a general downturn in the market. Angel Biotech (ABH) is like the pharmaceuticals and should make a good defensive stock to hold. IMHO

...The most interesting buying opportunities, I think, are to be found in pharmaceuticals. Rarely do these companies trade at a discount to the market. But this is just what is happening today. At the same time the dividend yield of the sector has rocketed.
There are only three occasions where the yield relative to the wider market has been so anomalously high: May 1980, April 1994 and March last year. On each occasion, this peak preceded a very rapid rally in share prices as investors recognised the gaping valuation gap. Fingers crossed this is the case again.
So what about the companies themselves? AstraZeneca,valued at 7.1 times prospective earnings, and GlaxoSmithKline, on 8.8 times, have rarely been cheaper.
Shire, compared to the other two, looks very expensive at almost 21 times net profits. However, the smaller speciality pharma group differs from its two larger and more illustrious rivals in having a bulging pipeline of new products and a rapidly expanding stream of earnings. ..

[stevefoster] 16/6/2009 00:05

This:



"The Food and Drug Administration on Monday said children shouldn't stop taking drugs that treat attention deficit hyperactivity disorder, or ADHD, despite a study showing the stimulants may be associated with sudden death.

A study released in the American Journal of Psychiatry found an association between the stimulants, which include drugs such as Ritalin, and sudden death in children who take the medicines."

This sort of thing tends to spook the markets.

[philo124] 15/6/2009 20:46

WHAT'S HAPPENING HERE??

[binladin] 10/6/2009 14:20

CHECK OUT PVR
TARGET 19P ONLY 4P NOW:
NEW FIND AND DOUBLING PRODUCTION:

[kamukak] 28/5/2009 15:21

Broker recommendation full details Date: 28 May, 2009


Broker: Goldman Sachs Company: Shire Pharmaceuticals


Recommendation:
upgrade to Buy from Neutral price target 1100p from 915p

[knockers2] 28/5/2009 13:26

big upgrade